New Jersey Administrative Code
Title 13 - LAW AND PUBLIC SAFETY
Chapter 45J - LIMITATIONS ON AND OBLIGATIONS ASSOCIATED WITH PRESCRIBER ACCEPTANCE OF COMPENSATION FROM PHARMACEUTICAL MANUFACTURERS
Subchapter 1 - LIMITATIONS ON AND OBLIGATIONS ASSOCIATED WITH PRESCRIBER ACCEPTANCE OF COMPENSATION FROM PHARMACEUTICAL MANUFACTURERS
Section 13:45J-1.6 - Bona fide services cap

Universal Citation: NJ Admin Code 13:45J-1.6
Current through Register Vol. 56, No. 6, March 18, 2024

A prescriber shall not accept more than $ 10,000 in the aggregate from all pharmaceutical manufacturers in any calendar year for the bona fide services of presentations as speakers at promotional activities, participation on advisory boards, and consulting arrangements. Payments for speaking at education events are not subject to this cap, but must be for fair market value and set forth in a written agreement. Payments for research activities and, consistent with N.J.A.C. 13:45J-1.4(a)10, payments for royalties and licensing fees are not subject to this cap.

Disclaimer: These regulations may not be the most recent version. New Jersey may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.